These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34663790)

  • 1. Molecular and genomic characterisation of a panel of human anal cancer cell lines.
    Guerra GR; Kong JC; Millen RM; Read M; Liu DS; Roth S; Sampurno S; Sia J; Bernardi MP; Chittleborough TJ; Behrenbruch CC; Teh J; Xu H; Haynes NM; Yu J; Lupat R; Hawkes D; Di Costanzo N; Tothill RW; Mitchell C; Ngan SY; Heriot AG; Ramsay RG; Phillips WA
    Cell Death Dis; 2021 Oct; 12(11):959. PubMed ID: 34663790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.
    Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM
    Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
    Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
    Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes.
    Aldersley J; Lorenz DR; Mouw KW; D'Andrea AD; Gabuzda D
    Mol Cancer Res; 2021 Aug; 19(8):1308-1321. PubMed ID: 33883185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
    Trilla-Fuertes L; Gámez-Pozo A; Nogué M; Busquier I; Arias F; López-Campos F; Fernández-Montes A; Ruiz A; Velázquez C; Martín-Bravo C; Pérez-Ruiz E; Asensio E; Hernández-Yagüe X; Rodrigues A; Ghanem I; López-Vacas R; Hafez A; Arias P; Dapía I; Solís M; Dittmann A; Ramos R; Llorens C; Maurel J; Campos-Barros Á; Fresno Vara JÁ; Feliu J
    Cancer; 2023 Aug; 129(16):2581-2592. PubMed ID: 37096763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
    Mouw KW; Cleary JM; Reardon B; Pike J; Braunstein LZ; Kim J; Amin-Mansour A; Miao D; Damish A; Chin J; Ott PA; Fuchs CS; Martin NE; Getz G; Carter S; Mamon HJ; Hornick JL; Van Allen EM; D'Andrea AD
    Clin Cancer Res; 2017 Jun; 23(12):3214-3222. PubMed ID: 27852700
    [No Abstract]   [Full Text] [Related]  

  • 7. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
    Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.
    Meulendijks D; Tomasoa NB; Dewit L; Smits PH; Bakker R; van Velthuysen ML; Rosenberg EH; Beijnen JH; Schellens JH; Cats A
    Br J Cancer; 2015 Apr; 112(8):1358-66. PubMed ID: 25871546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
    Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
    Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).
    Casadei Gardini A; Capelli L; Ulivi P; Giannini M; Freier E; Tamberi S; Scarpi E; Passardi A; Zoli W; Ragazzini A; Amadori D; Frassineti GL
    PLoS One; 2014; 9(3):e92071. PubMed ID: 24642661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention.
    Bernardi MP; Ngan SY; Michael M; Lynch AC; Heriot AG; Ramsay RG; Phillips WA
    Lancet Oncol; 2015 Dec; 16(16):e611-21. PubMed ID: 26678214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma.
    Soares PC; Abdelhay ES; Thuler LCS; Soares BM; Demachki S; Ferro GVR; Assumpção PP; Lamarão LM; Ribeiro Pinto LF; Burbano RMR
    BMC Gastroenterol; 2018 Feb; 18(1):30. PubMed ID: 29466950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines.
    Zhou QH; Deng CZ; Li ZS; Chen JP; Yao K; Huang KB; Liu TY; Liu ZW; Qin ZK; Zhou FJ; Huang W; Han H; Liu RY
    Cell Death Dis; 2018 Jun; 9(6):684. PubMed ID: 29880898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.
    Zhu X; Jamshed S; Zou J; Azar A; Meng X; Bathini V; Dresser K; Strock C; Yalamarti B; Yang M; Tomaszewicz K; Tjionas G; Mochel MC; Hutchinson L; Bledsoe JR
    Mod Pathol; 2021 May; 34(5):1017-1030. PubMed ID: 33483624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis.
    Cacheux W; Lièvre A; Richon S; Vacher S; El Alam E; Briaux A; El Botty R; Mariani P; Buecher B; Schnitzler A; Barbazan J; Roman-Roman S; Bièche I; Dangles-Marie V
    Int J Cancer; 2019 Oct; 145(7):1852-1859. PubMed ID: 30714617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris VK; Rashid A; Rodriguez-Bigas M; Das P; Chang G; Ohinata A; Rogers J; Crane C; Wolff RA; Eng C
    Oncologist; 2015 Nov; 20(11):1247-52. PubMed ID: 26382740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: a meta-analysis.
    Qin Y; Luan J; Zhou X; Li Y
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33704390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
    Mondaca S; Chatila WK; Bates D; Hechtman JF; Cercek A; Segal NH; Stadler ZK; Varghese AM; Kundra R; Capanu M; Shia J; Schultz N; Saltz L; Yaeger R
    Clin Colorectal Cancer; 2019 Mar; 18(1):e39-e52. PubMed ID: 30316684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts.
    Ito T; Takayanagi D; Sekine S; Hashimoto T; Shimada Y; Matsuda M; Yamada M; Hamamoto R; Kato T; Shida D; Kanemitsu Y; Boku N; Kohno T; Takashima A; Shiraishi K
    Sci Rep; 2023 Mar; 13(1):3587. PubMed ID: 36869079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
    Hamza A; Masliah-Planchon J; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Bourneix C; Delaye M; Goéré D; Dartigues P; Samalin E; Hilmi M; Lazartigues J; Girard E; Emile JF; Rigault E; Dangles-Marie V; Rioux-Leclercq N; de la Fouchardière C; Tougeron D; Casadei-Gardini A; Mariani P; Peschaud F; Cacheux W; Lièvre A; Bièche I
    Int J Cancer; 2024 Feb; 154(3):504-515. PubMed ID: 37908048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.